Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Coptis chinensis contains berberine as its primary bioactive alkaloid, which demonstrates potent antibacterial and anti-inflammatory effects through multiple cellular pathways. This traditional Chinese herb primarily works by inhibiting bacterial protein synthesis and modulating glucose metabolism via AMPK activation.
Reported Benefits (Provisional)
Origin & History
Huang Lian is derived from the rhizome of the Coptis chinensis plant, which is native to China. It is harvested and dried for use in herbal medicine.
Research Narrative (Provisional)
Scientific studies on Huang Lian have focused on its antimicrobial and anti-inflammatory properties. Some research has explored its potential in treating gastrointestinal disorders and infections.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
Huang Lian (Coptis chinensis) is a medicinal herb with limited macronutrient significance but rich in bioactive alkaloids. Primary bioactive compounds: Berberine (5–8% dry weight, the dominant alkaloid, averaging ~50–80 mg/g in rhizome), Coptisine (0.2–1.5% dry weight), Palmatine (0.5–1.0% dry weight), Epiberberine (0.3–0.8% dry weight), Columbamine (trace to 0.3% dry weight), and Worenine (minor alkaloid, trace amounts). Macronutrient profile per 100g dried rhizome (approximate): Carbohydrates 40–50g (primarily as structural polysaccharides and starches), Protein 8–12g (limited nutritional bioavailability due to alkaloid-protein binding), Dietary Fiber 15–20g, Fat 1–3g (predominantly unsaturated fatty acids including linoleic and oleic acid). Micronutrients: Magnesium (~120–150 mg/100g), Potassium (~300–400 mg/100g), Calcium (~80–100 mg/100g), Iron (~10–15 mg/100g), Zinc (~2–4 mg/100g), Manganese (~3–5 mg/100g). Minor phenolic compounds: Ferulic acid, chlorogenic acid, and quercetin derivatives at trace levels (1–5 mg/100g collectively). Bioavailability notes: Berberine has notably poor oral bioavailability (~5% absorption rate) due to P-glycoprotein efflux and first-pass metabolism; co-administration with sodium caprate or with Phellodendron amurense can enhance absorption by 3–5 fold. The alkaloid matrix is water-soluble and better extracted via decoction (traditional preparation), with ethanol extracts yielding higher berberine concentrations. Fat-soluble constituents have limited extraction in aqueous preparations.
Reported Mechanism (Provisional)
Berberine, the main alkaloid in Coptis chinensis, activates AMP-activated protein kinase (AMPK) to improve glucose uptake and insulin sensitivity. It disrupts bacterial cell wall synthesis by binding to DNA gyrase and topoisomerase IV enzymes. The compound also inhibits NF-κB signaling pathways, reducing inflammatory cytokine production and oxidative stress markers.
Clinical Narrative (Provisional)
Human trials with berberine from Coptis chinensis show significant anti-diabetic effects, with studies of 116-150 participants demonstrating 1-2 mg/dL reductions in HbA1c levels over 12 weeks. Antibacterial studies indicate minimum inhibitory concentrations of 32-128 μg/mL against H. pylori strains. Limited randomized controlled trials exist specifically for whole Coptis extract, with most research focusing on isolated berberine compounds. Evidence quality ranges from moderate to high for metabolic benefits but remains preliminary for other claimed effects.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.